Neonatal hyperbilirubinemia has traditionally been screened by either total serum bilirubin or transcutaneous bilirubin. Whole blood bilirubin (TwB) by the GEM Premier 4000® blood gas analyzer (GEM) is a relatively new technology and it provides fast bilirubin results with a small sample volume and can measure co-oximetry and other analytes. Our clinical study was to evaluate the reliability of TwB measured by the GEM and identify analytical and clinical factors that may contribute to possible bias.
440 consecutive healthy newborn samples that had plasma bilirubin ordered for neonatal hyperbilirubinemia screening were included. TwB was first measured using the GEM, after which the remainder of the blood was spun and plasma neonatal bilirubin was measured using the VITROS 5600® (VITROS).
62 samples (14%) were excluded from analysis due to failure in obtaining GEM results. Passing-Bablok regression suggested that the GEM results were negatively biased at low concentrations of bilirubin and positively biased at higher concentrations relative to the VITROS results (y = 1.43x-61.13). Bland-Altman plots showed an overall negative bias of the GEM bilirubin with a wide range of differences compared to VITROS. Both hemoglobin concentration and hemolysis affected the accuracy of the GEM results. Clinically, male infants had higher mean bilirubin levels, and infants delivered by caesarean section had lower hemoglobin levels. When comparing the number of results below the 40th percentile and above the 95th percentile cut-offs in the Bhutani nomogram which would trigger discharge or treatment, GEM bilirubin exhibited poor sensitivity and poor specificity in contrast to VITROS bilirubin.
An imperfect correlation was observed between whole blood bilirubin measured on the GEM4000® and plasma bilirubin on the VITROS 5600®. The contributors to the observed differences between the two instruments were specimen hemolysis and the accuracy of hemoglobin measurements, the latter of which affects the calculation of plasma-equivalent bilirubin. Additionally, the lack of standardization of total bilirubin calibration particularly in newborn specimens, may also account for some of the disagreement in results.
American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114(1):297–316. CrossRef
Raimondi F, Ferrara T, Borrelli AC, Schettino D, Parrella C, Capasso L. Neonatal hyperbilirubinemia: a critical appraisal of current guidelines and evidence. J Pediatr Neonatal individualized Med. 2012;1(1):25–32.
VITROS Chemistry Products BuBc Slides, TBIL Slides and Bilirubin Supplement [Package inserts]. http://techdocs.orthoclinical.com/TechDocs/TechDocSearch.aspx?tID=0&culture=en-ca. Accessed 4 Nov 2016.
Langbaum ME, Farber SJ, Rosenthal P. Automated total and neonatal bilirubin values in newborns: is a distinction clinically relevant? Clin Chem. 1992;38(9):1690–3. PubMed
Brett EM, Hicks JM, Powers DM, Rand RN. Delta bilirubin in serum of pediatric patients: correlations with age and disease. Clin Chem. 1984;30(9):1561–4. PubMed
World Health Organization. WHO recommendations for the prevention and treatment of postpartum haemorrhage. http://apps.who.int/iris/bitstream/10665/75411/1/9789241548502_eng.pdf. Accessed 4 Nov 2016.
Shirvani F, Radfar M, Hashemieh M, Soltanzadeh MH, Khaledi H, Mogadam MA. Effect of timing of umbilical cord clamp on newborns’ iron status and its relation to delivery type. Arch Iran Med. 2010;13(5):420–5. PubMed
- Limitations and opportunities of whole blood bilirubin measurements by GEM premier 4000®
Arianne Y. K. Albert
Martha E. Lyon
- BioMed Central
Neu im Fachgebiet Pädiatrie
Meistgelesene Bücher aus dem Fachgebiet
Mail Icon II